These Healthcare stocks are trading higher:
-Chembio Diagnostics Inc (CEMI) stock is trading at $6.18, an increase of $4.12, or 193.2%, on high volume. Chembio Diagnostics gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.00. Chembio Diagnostics next reports earnings on August 5.
-Neurometrix Inc (NURO) stock is trading at $26.50, an increase of $16.46, or 153.88%, on high volume. Neurometrix Inc gets a Sentiment Score of Very Bullish from InvestorsObserver. Neurometrix Inc next reports earnings on July 22.
-Forward Pharma A/S (FWP) stock is trading at $17.03, a gain of $3.8, or 30.66%, on low volume. Forward Pharma ADR gets a Sentiment Score of Bullish from InvestorsObserver.
-Cassava Sciences Inc (SAVA) stock is trading at $112.81, an increase of $21.98, or 23.38%, on moderate volume. Cassava Sciences Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $124.50. Cassava Sciences Inc next reports earnings on August 11.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Neurobo Pharmaceuticals Inc (NRBO) stock is trading at $3.39, a drop of $0.58, or 14.86%, on average volume. Neurobo Pharmaceuticals Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00. Neurobo Pharmaceuticals Inc next reports earnings on August 10.-Healthcare Services Group, Inc. (HCSG) stock is trading at $27.47, a drop of $3.25, or 11.62%, on high volume. Healthcare Svcs Gp gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $30.25.
-Lumos Pharma Inc (LUMO) stock is trading at $8.35, a decline of $1.02, or 10.89%, on high volume. Lumos Pharma Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $31.50. Lumos Pharma Inc next reports earnings on August 12.
-Ikena Oncology Inc (IKNA) stock is trading at $11.97, a drop of $1.39, or 10.42%, on average volume. Ikena Oncology Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $27.00. Ikena Oncology Inc next reports earnings on August 12.
